期刊文献+

阿维A对寻常型银屑病皮肤组织中Th1、Th17细胞的影响

下载PDF
导出
摘要 采用免疫荧光双重标记法检测健康对照、阿维A治疗前、后寻常型银屑病患者皮损中Th1细胞(CD3^+IFN-γ^+)和Th17细胞(CD3^+IL-17^+)的数量变化。阿维A治疗前的寻常型银屑病患者皮损真皮浅层T细胞数量、Th1细胞数量、Th17细胞数量较健康对照组T细胞、Th1细胞、Th17细胞明显增多(P<0.01);治疗后较治疗前皮损真皮浅层T细胞、Th1细胞、Th17细胞数明显下降(P<0.01)。阿维A治疗寻常型银屑病的作用可能涉及到其对Th1和Th17细胞的影响;同Th1细胞一样,Th17细胞可能是寻常型银屑病病情演变过程中关键的T细胞亚群之一。
出处 《中国麻风皮肤病杂志》 2010年第5期336-338,共3页 China Journal of Leprosy and Skin Diseases
基金 教育部博士点基金新教师项目(编号:20070698071) 陕西省科学技术研究发展计划项目[编号:2008K15-06(14)]
  • 相关文献

参考文献12

  • 1Kirby B,Griffiths CE.Novel immune-based therapies for psoriasis.Br J Dermatol 2002;146:546-551.
  • 2Liang SC,Tan XY,Luxenberg DP,et al.Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.J Exp Med 2006;203:2271-2279.
  • 3Lowes MA,Kikuchi T,Fuentes-Duculan J,et al.Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.J Invest Dermatol 2008;17:1207-1211.
  • 4Wynn TA.Th-17:a giant step from Th-1 and Th-2.Nat Immunol 2005;6:1069-1070.
  • 5Harrington LE,Mangan PR,Weaver CT.Expanding the effector CD4+T cell repertoire:the Th17 lineage.Curr Opin Immunol 2006;18:349-356.
  • 6Weber KS,Miller MJ,Allen PM.Th17 cells exhibit a distinct calcium profile from Th1 and Th2 cells and have Th1-like motility and NF-AT nuclear localization.J Immunol 2008;180:1442-1450.
  • 7Witowski J,Ksiazek K,Jrres A.Interleukin-17:a mediator of inflammatory responses.Cell Mol Life Sci 2004;61(5):567-579.
  • 8彭振辉,牛新武.维A酸类药物与皮肤病[J].中国皮肤性病学杂志,2004,18(6):374-378. 被引量:60
  • 9Iwata M,Eshima Y,Kagechika H.Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.International Immunology 2003;15(8):1017-1025.
  • 10何玉清,张锡宝,李常兴,刘玉梅,黄振明,陈绍谦.阿维A与甲氨喋呤治疗银屑病的疗效对比分析[J].中国皮肤性病学杂志,2005,19(6):346-348. 被引量:9

二级参考文献28

  • 1Dawson MI,Park JH,Chen G,et al. Retinoic acid(RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC)activity by retinoids: a potential role for trans-RA-induced ZBP-
  • 2Xu Feng, Zhen-Hui Peng, Wei Di, et al. Suprbasal expression of a dominant-negative RXR-alpha mutant in transgenic mouse epider mis impairs regulation of gene transcription and basal kerstinocyte proliferation by RAR-selective retinouds[J]. GENES&amp;DECEL
  • 3Makoto Iwata, Yuko Eshima, Hiroyuki Kagechika, et al. Retinoic acids exert direct effects or T cells to suppress Thl development and enhance Th2 development via retinoic acid receptors[J]. International Immunology, 2003,15 (8): 1017- 1025.
  • 4Mohamad Mohty, Silvia Morbelli, Daniel Isnardon, et al. All-trans retinoic acid skews monocyte differentiationinto interleukin-12-secreting dendritic-like cells[J]. British Journal of Haematology Vol ume, 2003,122(5): 829.
  • 5Reichrath J, Mittmann M, Kamradt J,et al. Expression of retinoid X receptors(alpha, beta, gamma) and retinoic acid receptors (alpha, beta, gamma) in normal human skin: an immunohistologicalevaluation[J]. Histochem J ,1997,29(2): 127-33.
  • 6Torma H, Karlsson T,Michaelsson G,et al. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin[J]. Acta Derm Venereol,2000,80(1) :4-9.
  • 7Boudjelal M, Wang Z, Voorhees JJ, et al. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes[J]. Cancer res, 2000 , 60(8): 2247- 52.
  • 8Xu XC, Wong WY, Goldberg L,et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis [J]. Cancer Rra,2001, 61(11) :4306-10.
  • 9Feldman SR, Fleischer AB Jr, Reboussin DM,et al. The self-administered psoriasis area and severity index is valid and reliable[ J]. J Invest Dermatol, 1996,106( 1 ) : 183 - 186.
  • 10Wiegand UW, Chou RC. Pharmacokinetics of acitretin and etretinate[J].J Am Acad Dermatol, 1998, 39(2 Pt 3) : S25 -33.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部